Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.55 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.38 |
| ▸ | CDC25B | P30305 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27414793 | 1.00 | ALOX15 (0.68) | ALOX15MEN1CYP3A4KMT2APTPN1 | |
| SCHEMBL5693809 | 0.94 | ALOX15 (0.62) | ALOX15MEN1CYP3A4KMT2APTPN1 | |
| SCHEMBL5693810 | 0.94 | ALOX15 (0.62) | ALOX15MEN1CYP3A4KMT2APTPN1 | |
| SCHEMBL27414791 | 0.92 | ALOX15 (0.68) | ALOX15MEN1CYP3A4KMT2APTPN1 | |
| SCHEMBL27414795 | 0.92 | ALOX15 (0.68) | ALOX15MEN1CYP3A4KMT2APTPN1 | |
| SCHEMBL7941585 | 0.90 | ALOX15 (0.70) | ALOX15MEN1CYP3A4KMT2APTPN1 | |
| SCHEMBL7941578 | 0.90 | ALOX15 (0.70) | ALOX15MEN1CYP3A4KMT2APTPN1 | |
| SCHEMBL27414797 | 0.88 | ALOX15 (0.67) | ALOX15MEN1CYP3A4KMT2APTPN1 | |
| SCHEMBL17244807 | 0.88 | ALOX15 (0.67) | ALOX15MEN1CYP3A4KMT2APTPN1 | |
| SCHEMBL7941581 | 0.85 | ALOX15 (0.59) | ALOX15MEN1CYP3A4KMT2APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11633710-B2 | Systems and methods for processing gases | TRANSFORM MATERIALS LLC (US) | 2023-04-25 | — | — | US | disclosed |
| US-20210245133-A1 | SYSTEMS AND METHODS FOR PROCESSING GASES | CARBOGENESIS LLC | 2021-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210245133-A1 | SYSTEMS AND METHODS FOR PROCESSING GASES | F2, AHR, ACSS2 | ALOX15 193/4885MEN1 1185/4885CYP3A4 218/4885 |
| US-11633710-B2 | Systems and methods for processing gases | F2, AHR, ACSS2 | ALOX15 193/4885MEN1 1185/4885CYP3A4 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.